EUVIMEDEUVIMED entdecken
Crossref

The molecular modification, expression, and the antibacterial effects studies of human lysozyme

Kewei Xu, Chuanyuan Ma, Changyun Wu, Dan Wu

Bioscience, Biotechnology, and Biochemistry · 2024

DOI: 10.1093/bbb/zbae023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, 2024. Verfasst von Kewei Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: SINOPEC Key Laboratory of Petroleum Accumulation Mechanisms, Wuxi, Jiangsu, China. Hauptthemen laut MEDLINE: Muramidase, Anti-Bacterial Agents, Recombinant Proteins, Staphylococcus aureus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human lysozyme (hLYZ) has attracted considerable research attention due to its natural and efficient antibacterial abilities and widespread uses. In this study, hLYZ was modified to enhance its enzyme activity and expressed in a Pichia pastoris expression system. A combination mutant HZM(2R-K)-N88D/V110S demonstrated the highest enzyme activity (6213 ± 164 U/mL) in shake flasks, which was 4.07-fold higher when compared with the original strain. Moreover, the recombinant P. pastoris was inducted in a 3 L bioreactor plus methanol/sorbitol co-feeding. After 120 h induction, the antibacterial activity of hLYZ reached 2.23 ± 0.12 × 105 U/mL, with the specific activity increasing to 1.89 × 105 U/mg, which is currently the highest specific activity obtained through recombinant expression of hLYZ. Also, hLYZ supernatants showed 2-fold inhibitory effects toward Staphylococcus aureus and Micrococcus lysodeikticus when compared with HZM(2R-K). Our research generated a hLYZ mutant with high antibacterial capabilities and provided a method for screening of high-quality enzymes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MuramidaseAnti-Bacterial AgentsRecombinant ProteinsStaphylococcus aureusHumansBioreactorsMicrococcusGene ExpressionMutationSaccharomycetalesMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Pichia pastorisantibacterial effectsexpressionhuman lysozymemolecular modification

Substanzen

MuramidaseAnti-Bacterial AgentsRecombinant Proteins

Autor:innen und Institutionen

  • SINOPEC Key Laboratory of Petroleum Accumulation Mechanisms, Wuxi, Jiangsu, China.
  • Wuxi Research Institute of Petroleum Geology, Research Institute of Petroleum Exploration & Production, SINOPEC, Wuxi, Jiangsu, China.
  • The Key Laboratory of Industrial Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, Jiangsu, China.

Zitieren

APA

Xu, K., Ma, C., Wu, C., & Wu, D. (2024). The molecular modification, expression, and the antibacterial effects studies of human lysozyme. Bioscience, Biotechnology, and Biochemistry. https://doi.org/10.1093/bbb/zbae023

Vancouver

Xu K, Ma C, Wu C, Wu D. The molecular modification, expression, and the antibacterial effects studies of human lysozyme. Bioscience, Biotechnology, and Biochemistry. 2024. doi:10.1093/bbb/zbae023

BibTeX
@article{Xu2024,
  author = {Xu, Kewei and Ma, Chuanyuan and Wu, Changyun and Wu, Dan},
  title = {The molecular modification, expression, and the antibacterial effects studies of human lysozyme},
  journal = {Bioscience, Biotechnology, and Biochemistry},
  year = {2024},
  doi = {10.1093/bbb/zbae023}
}
Kostenlos starten →